Cargando…
Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study – a randomised, double-blind cross-over study using mixed microbiota from healthy donors
INTRODUCTION: Several studies have demonstrated dysbiosis in irritable bowel syndrome (IBS). Therefore, faecal microbiota transplantation, whose effect and safety have been proven in Clostridioides difficile infections, may hold promise in other conditions, including IBS. Our study will examine the...
Autores principales: | Hurych, Jakub, Vejmelka, Jiri, Hlinakova, Lucie, Kramna, Lenka, Larionov, Vladyslav, Kulich, Michal, Cinek, Ondrej, Kohout, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237876/ https://www.ncbi.nlm.nih.gov/pubmed/35760542 http://dx.doi.org/10.1136/bmjopen-2021-056594 |
Ejemplares similares
-
Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study
por: Jitsumura, Maki, et al.
Publicado: (2018) -
FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder
por: Chen, Ye, et al.
Publicado: (2022) -
PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial
por: Woodhouse, Charlotte Alexandra, et al.
Publicado: (2019) -
Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial
por: Pai, Nikhil, et al.
Publicado: (2017) -
STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2019)